Prev: Measurement of antinuclear antibodies: assessment of different test systemsNext: Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?

Record 041 · Research · 2011
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases
Arthritis & Rheumatism · requested inclusion
“In 918 healthy individuals and 153 patients with autoimmune rheumatic diseases, the ANA-HEp-2 pattern profile differed sharply: nuclear homogeneous, coarse speckled, and centromeric patterns occurred exclusively in ARD patients, while the dense fine speckled pattern occurred only in healthy individuals.”
In 918 healthy individuals and 153 patients with autoimmune rheumatic diseases, the ANA-HEp-2 pattern profile differed sharply: nuclear homogeneous, coarse speckled, and centromeric patterns occurred exclusively in ARD patients, while the dense fine speckled pattern occurred only in healthy individuals. Candidate notes: ANA present in 118/918 healthy individuals (12.9%) and 138/153 ARD patients (90.2%) Nuclear homogeneous, coarse speckled, and centromeric patterns appeared exclusively in ARD patients; dense fine speckled pattern only in healthy individuals None of 40 reevaluated healthy ANA-positive individuals developed ARDs after 3.6-5.0 years; 29/40 (72.5%) remained ANA positive Limits noted in the record: Retrospective data retrieval at a single Brazilian center Only 40 healthy ANA-positive individuals were reevaluated, over a relatively short 3.6-5.0 year window A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- healthy-people
- pattern
- positive-ana
Research



